Invention Grant
- Patent Title: Arylsulfonylamino hydroxamic acid derivatives
- Patent Title (中): 芳基磺酰氨基异羟肟酸衍生物
-
Application No.: US130922Application Date: 1998-08-06
-
Publication No.: US6107337APublication Date: 2000-08-22
- Inventor: Ralph P. Robinson
- Applicant: Ralph P. Robinson
- Applicant Address: NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: NY New York
- Main IPC: C07C311/19
- IPC: C07C311/19 ; C07C311/20 ; A61K31/35 ; A61K31/216 ; A61K31/50 ; A61K31/5375
Abstract:
A compound of the formula ##STR1## wherein n, X, R.sup.3, R.sup.4 and Ar are as defined above, useful in the treatment of a condition selected from the group consisting of arthritis, cancer, tissue ulceration, restenosis, periodontal disease, epidermolysis bullosa, scleritis, bone resorption, loosening of artificial joint implants, atherosclerosis, multiple sclerosis, occular angiogenisis and other diseases characterized by matrix metalloproteinase activity, AIDS, sepsis, septic shock and other diseases involving the production of TNF.
Public/Granted literature
- US5445659A Partial oxidation of products of liquefaction of plastic materials Public/Granted day:1995-08-29
Information query